INFLUENZA PATHOGENESIS AND IMMUNOLOGY RESEARCH CENTER:T CELL RESPONSES

流感发病机制和免疫学研究中心：T 细胞反应

• 批准号: 8357561
• 负责人: John David Altman
• 金额: $ 12.34万
• 依托单位: EMORY UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-08-01 至 2012-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8357561
• 关键词: Attenuated; CD4 Positive T Lymphocytes; CD8B1 gene; California; Flushield; Funding; Grant; Human; Immunology; Inactivated Vaccines; Influenza; Life; Measures; National Center for Research Resources; Pathogenesis; Primates; Principal Investigator; Production; Proteins; Recombinants; Research; Research Infrastructure; Resources; Seasons; Source; T cell response; United States National Institutes of Health; Vaccinated; Vaccination; Vaccines; Vesicular stomatitis Indiana virus; Virus; cost; influenza virus vaccine; pandemic disease; response

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. For assessment of human T cell responses to influenza A and B viruses, we have constructed a large panel of replication-restricted, recombinant vesicular stomatitis viruses, each expressing a single protein from a variety of influenza strains. The complete panel covers the HA and NA proteins from influenza vaccine strains used from 2000-2011, as well as the internal components of the A/California/04/09 strain from the recent pandemic, the PR8 strain that is used for production of the conventional vaccine, and the A/Ann Arbor/06/60 strain that is used for the production of the live-attenuated FluMist vaccine. We are using these to measure T cell responses in 60 donors who were vaccinated during the 2010-2011 season. In general, CD8 T cell responses to vaccination have been low-to-undetectable, a result that was not unexpected, especially for the conventional inactivated vaccine. In contrast, CD4 T cell responses are more frequent, with a response range of 0-631 per million CD4 cells.

这个子项目是利用这些资源的众多研究子项目之一